Cadila Healthcare inks drug discovery pact with Eli Lilly
Cadila Healthcare Ltd., a research-oriented pharmaceutical company in India belonging to Zydus group, said it has inked a new drug discovery and development pact with Eli Lilly and Co. focused in the area of cardiovascular research.
Eli Lilly and Company has acquired SGX Pharmaceuticals, a San Diego-based biotechnology company focused on drug discovery and development in the area of oncology.